Market report
Pharmaceutical tenders in Czechia — market report, August 2026
Pharmaceutical tenders in Czechia in August 2026: 9,997 tenders published (-5% month on month, +46% year on year), estimated at €74,609,185 in total, and 9,892 contracts awarded (-6% month on month, +41% year on year), worth €63,797,904 (awarded value). Buyers with the most tenders: Institut klinické a experimentální medicíny (803), Fakultní nemocnice Olomouc (795) and Krajská zdravotní, a.s. (696); most contracts won: ROCHE s.r.o. (306), Janssen-Cilag s.r.o. (240) and Takeda Pharmaceuticals Czech Republic s.r.o. (227). On average 2.5 bids per contract; 61% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 9,997
- Contracts awarded
- 9,892
- Contract value awarded
- €63,797,904
- Bids per contract
- 2.5
The highlighted bar is August 2026. Hover a bar for its figure; the table below has every value.
| Figure | August 2026 | July 2026 | Change | August 2025 | Change |
|---|---|---|---|---|---|
| Tenders published | 9,997 | 10,519 | -5% | 6,825 | +46% |
| Estimated value | €74,609,185 | €15,466,813 | +382% | €21,776,977 | +243% |
| Buyers | 82 | 86 | -5% | 76 | +8% |
| Contracts awarded | 9,892 | 10,527 | -6% | 7,001 | +41% |
| Contract value (awarded) | €63,797,904 | €537,445,731 | -88% | €84,882,840 | -25% |
| Winners | 369 | 409 | -10% | 339 | +9% |
| Bids per contract | 2.5 | 5.1 | — | 5.0 | — |
| Single-bid contracts | 61% | 53% | — | 40% | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ROCHE s.r.o. | 306 |
| 2 | Janssen-Cilag s.r.o. | 240 |
| 3 | Takeda Pharmaceuticals Czech Republic s.r.o. | 227 |
| 4 | AbbVie s.r.o. | 181 |
| 5 | ViaPharma s.r.o. | 167 |
| 6 | BAYER s.r.o. | 164 |
| 7 | Amgen s.r.o. | 153 |
| 8 | Avenier a.s. | 149 |
| 9 | Merck Sharp & Dohme s.r.o. | 143 |
| 10 | Phoenix - Plzen | 131 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Medicines and pharmaceuticals
Questions and answers
- How many pharmaceutical tenders were published in Czechia in August 2026?
- 9,997 (by 82 buyers); for comparison, July 2026: 10,519, August 2025: 6,825.
- Who won the most pharmaceutical tenders in Czechia in August 2026?
- By number of contracts: ROCHE s.r.o. (306), Janssen-Cilag s.r.o. (240), Takeda Pharmaceuticals Czech Republic s.r.o. (227), AbbVie s.r.o. (181) and ViaPharma s.r.o. (167); 369 companies won contracts in all.
- Which buyers published the most pharmaceutical tenders in August 2026?
- Institut klinické a experimentální medicíny (803), Fakultní nemocnice Olomouc (795), Krajská zdravotní, a.s. (696), Fakultní nemocnice Brno (594) and Fakultní nemocnice Bulovka (410).
- How competitive were pharmaceutical tenders in Czechia in August 2026?
- On average 2.5 bids per contract (134 contracts with a known number of bids); 61% of contracts had a single bid.
- What were the contracts worth in August 2026?
- €63,797,904 (awarded value, 9,892 contracts); median about €220,000.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.